Latest Regulatory Challenges News

WA Kaolin has successfully recapitalised its balance sheet by approximately A$16.1 million through a partially underwritten entitlement offer and significant debt reduction, positioning the company for operational growth at its Wickepin kaolin project.

Humm Group reported a 5.1% rise in average assets under management to $5.4 billion in 3Q26, despite lower loan originations and ongoing corporate irregular costs. Credit quality remains stable as the company navigates macroeconomic headwinds and strategic product transitions.

Australian Dairy Nutritionals has closed the gap on its recent Entitlement Offer by placing 25 million shortfall shares, raising an additional $0.7 million and bringing total proceeds to $1.2 million.

Energy Transition Minerals has secured a non-binding MOU with Traxys Europe for the potential exclusive offtake of tin, tantalum, and niobium concentrates from its Penouta mine, positioning the project as a strategic Western source of critical minerals.

WA Kaolin is seeking up to A$34.9 million through a fully underwritten entitlement offer aimed at restructuring its balance sheet, reducing shareholder loans, and funding operational improvements at its Wickepin kaolin project.

Macquarie Bank Limited has posted a robust FY2026 result, with net profit attributable to ordinary equity holders soaring 74% to AUD 6.011 billion, underpinned by strong performances in its Banking and Financial Services and Commodities and Global Markets divisions.

Block, Inc. reported a robust Q1 2026 with AI-powered productivity gains, strong Cash App and Square growth, and a $5 billion share buyback boost. Despite a GAAP net loss due to restructuring and legal costs, the fintech giant raised its full-year outlook, signaling confidence in its AI-led transformation.

Light & Wonder posted modest revenue growth in Q1 2026, driven by strong Gaming and iGaming performances, while net income fell sharply due to legacy legal costs. The company maintains disciplined capital management amid ongoing macro pressures.

Axel REE reports thick, shallow rare earth mineralisation with strong heavy rare earth enrichment at Woolrich, underpinning plans for an Indicated resource upgrade and in-situ recovery trials.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Manuka Resources has drawn down a US$26 million tranche of a US$30 million debt facility, exited care and maintenance at Wonawinta, and signed a major mining contract as it targets production restart in late Q2 2026.

Blackstone Minerals has cleared a key regulatory hurdle at its Mankayan Copper-Gold Project, lifting a Cease and Desist Order and initiating a Pre-Feasibility Study. The company also strengthened its board with mining veteran Mark Williams and reported a solid cash position of $14.6 million.